about
Emerging endoscopic imaging technologies for bladder cancer detectionBacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccineClinical outcome of primary versus secondary bladder carcinoma in situTherapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trialsPredictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project.Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.Computed tomography urography for diagnosing bladder cancer.Haematuria 1: risk factors, clinical evaluation and laboratory investigations.Bacillus Calmette-Guérin in the management of superficial bladder cancer.Photodynamic diagnosis for follow-up of carcinoma in situ of the bladder.Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.Image-Guided Transurethral Resection of Bladder Tumors - Current Practice and Future Outlooks.Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1).Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under-reported malignancy.Different subtypes of carcinoma in situ of the bladder do not have a different prognosis.Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
P2860
Q26853736-D012D7F2-AE0F-474F-83A2-C03AF14E0FFCQ27006765-5478E2BA-AA1B-43DF-93B6-AA6CCC31B906Q34205568-58C543E7-6B32-4A93-976C-A44E57433D26Q34994530-3A94E40C-2ECF-4BAA-9692-C4D4D7844C71Q35891583-D673C899-3976-4352-A1ED-FB617FAA5AEDQ36286371-43E43492-24B1-4CB8-B696-401B8CD37CF6Q36552202-1051AB44-61EE-4EB1-B385-991D86844C0EQ36937102-67C40B5C-0626-4C5F-BAF9-8D44A428CDA1Q37197525-9817A464-B462-4910-A751-92872D921731Q38535982-E16D89E1-B298-40C0-8BBB-151C03C6C860Q38610684-1574CE52-0268-4809-AC81-4EB215CDDC5FQ38639727-56B9B288-8019-4F9E-BF6F-4528D2C42FFAQ40026591-F95C7145-28F5-4848-9AB7-83B3B4E44D5CQ44778209-88FB0DC6-3954-4DED-89EC-F3D65118D9EAQ53120782-30396077-FECE-4B87-971E-473246B7EFE3Q53239378-862C094F-A7B2-4C28-816B-4C955367C3E8
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Bladder carcinoma in situ in 2003: state of the art.
@ast
Bladder carcinoma in situ in 2003: state of the art.
@en
type
label
Bladder carcinoma in situ in 2003: state of the art.
@ast
Bladder carcinoma in situ in 2003: state of the art.
@en
prefLabel
Bladder carcinoma in situ in 2003: state of the art.
@ast
Bladder carcinoma in situ in 2003: state of the art.
@en
P1433
P1476
Bladder carcinoma in situ in 2003: state of the art.
@en
P2093
P304
P356
10.1016/J.EURURO.2003.09.013
P407
P577
2004-02-01T00:00:00Z